The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
Transfer rumors, news: Arsenal, Chelsea, Man United eye Stankovic
Feb 13, 2026, 04:00 AM ETArsenal, Chelsea and Manchester...
Team USA men’s hockey beats Latvia during opening game
IE 11 is not supported. For an optimal experience...
Early voting expanding this weekend in Rio Rancho
LAWMAKERS TO DISCUSS BILLS THAT ENSURE ACCESS TO HEALTH...
TOMBS Announce Northeast U.S. & Canada Shows With REPLICANT
New Jersey's experimental metal collective Tombs are hitting the...